Business Description
L&C BIO Co Ltd
ISIN : KR7290650001
Description
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Equity-to-Asset | 0.57 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 1.06 | |||||
Interest Coverage | 1.71 | |||||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | 2.73 | |||||
Beneish M-Score | -2.47 | |||||
WACC vs ROIC |
Growth Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 25.6 | |||||
3-Year EBITDA Growth Rate | 66.9 | |||||
3-Year EPS without NRI Growth Rate | 62.6 | |||||
3-Year Book Growth Rate | 34.8 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 53.42 | |||||
9-Day RSI | 49.33 | |||||
14-Day RSI | 46.02 | |||||
6-1 Month Momentum % | -5.36 | |||||
12-1 Month Momentum % | -45.55 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.11 | |||||
Quick Ratio | 1.11 | |||||
Days Inventory | 463.45 | |||||
Days Sales Outstanding | 93.93 | |||||
Days Payable | 36.16 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.6 | |||||
3-Year Dividend Growth Rate | 26 | |||||
Forward Dividend Yield % | 0.6 | |||||
5-Year Yield-on-Cost % | 0.6 | |||||
3-Year Average Share Buyback Ratio | -1.2 | |||||
Shareholder Yield % | 0.97 |
Profitability Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 48.5 | |||||
Operating Margin % | 16.19 | |||||
Net Margin % | -8.51 | |||||
FCF Margin % | -56.48 | |||||
ROE % | -4.06 | |||||
ROA % | -2.29 | |||||
ROIC % | 5.08 | |||||
ROC (Joel Greenblatt) % | 76.27 | |||||
ROCE % | 44.75 | |||||
Years of Profitability over Past 10-Year | 9 |
GF Value Rank
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 5.67 | |||||
PB Ratio | 2.72 | |||||
Price-to-Tangible-Book | 2.65 | |||||
EV-to-EBIT | 5.94 | |||||
EV-to-EBITDA | 5.59 | |||||
EV-to-Revenue | 6.16 | |||||
EV-to-FCF | -10.91 | |||||
Earnings Yield (Greenblatt) % | 16.84 | |||||
FCF Yield % | -10.13 | |||||
Forward Rate of Return (Yacktman) % | 15.95 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
L&C BIO Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil â‚©) | 70,030.988 | ||
EPS (TTM) (â‚©) | -298.975 | ||
Beta | 1.18 | ||
Volatility % | 46.35 | ||
14-Day RSI | 46.02 | ||
14-Day ATR (â‚©) | 636.762732 | ||
20-Day SMA (â‚©) | 16784.5 | ||
12-1 Month Momentum % | -45.55 | ||
52-Week Range (â‚©) | 15000 - 33550 | ||
Shares Outstanding (Mil) | 22.68 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
L&C BIO Co Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
L&C BIO Co Ltd Stock Events
Event | Date | Price(â‚©) | ||
---|---|---|---|---|
No Event Data |
L&C BIO Co Ltd Frequently Asked Questions
What is L&C BIO Co Ltd(XKRX:290650)'s stock price today?
When is next earnings date of L&C BIO Co Ltd(XKRX:290650)?
Does L&C BIO Co Ltd(XKRX:290650) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |